CR Bard (NYSE: BCR) reported earnings on Jan. 31. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), CR Bard met expectations on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share grew significantly.

Gross margins dropped, operating margins dropped, net margins grew.

Revenue details
CR Bard logged revenue of $762.6 million. The 19 analysts polled by S&P Capital IQ hoped for a top line of $757.9 million on the same basis. GAAP reported sales were 1.4% higher than the prior-year quarter's $751.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.70. The 22 earnings estimates compiled by S&P Capital IQ predicted $1.67 per share. GAAP EPS of $1.52 for Q4 were 17% higher than the prior-year quarter's $1.30 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 62.3%, 20 basis points worse than the prior-year quarter. Operating margin was 27.4%, 200 basis points worse than the prior-year quarter. Net margin was 16.8%, 170 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $745.4 million. On the bottom line, the average EPS estimate is $1.62.

Next year's average estimate for revenue is $3.06 billion. The average EPS estimate is $6.83.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 264 members out of 273 rating the stock outperform, and nine members rating it underperform. Among 105 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 103 give CR Bard a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CR Bard is hold, with an average price target of $103.47.

Is CR Bard the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.